TL1 Training Program for Predoctoral Students in Clinical and Translational Science

Eligibility

Individuals selected for research training supported by NRSA institutional training grants must be citizens or non-citizen nationals of the United States, or must have been lawfully admitted to the United States for permanent residence, i.e., in possession of a currently valid Alien Registration Receipt Card I-551, or some other legal verification of legal admission as a permanent resident. Non-citizen nationals are generally persons born in outlying possessions of the United States (e.g., American Samoa and Swains Island). Individuals on temporary or student visas are not eligible for Kirschstein-NRSA support. In addition, trainees must be able to commit full-time effort in the program at the time of appointment and agree to all NRSA requirements.

Program Description

The University of Kentucky TL1 Training Program in Clinical and Translational Science is designed to train exceptional professional graduate students (MD, MD/PhD, DMD, PharmD students or PhD level graduate students) with skills required to develop a career in multidisciplinary clinical and translational research in health related fields. The fundamental principal of the TL1 program is to provide clinical research training that is rigorous and effectively integrated with ongoing professional or graduate research programs.

The TL1 support will provide trainees access to:

  • a solid foundation in core clinical and translational research competencies;
  • discipline-specific training based on coursework;

  • research training at the cutting edge of the specific science.

Students will be required to participate in monthly CTS Seminars, present at the CCTS Spring Conference, attend a Responsible Conduct of Clinical Research Course and/or attend the Clinical and Research Ethics lecture series, and satisfy all NRSA requirements.

Application Process

  • application form
  • Research Plan:  A brief description of the research project, specific aims, experimental approaches, and anticipated outcomes (no more than 7 pages; Specific Aims 1 page and Research Strategy 6 pages)
  • Career Goals and Objectives:  A clear concise description of the applicant's short and long term career goals.  A description of how this award fits into the applicant's future research career development (no more than 1 page)
  • Career Development/Training Plan:  The career development/training plan should be consistent with the applicant's prior research experience.  A description of research training, skills and knowledge the applicant will acquire as a result of this award and how this training enhances the proposed research plan and candidate's career goals (no more than 2 pages)
  • Applicant's NIH biosketch
  • Doctoral dissertation advisor/mentor's NIH biosketch 
  • letter of support from doctoral dissertation advisor/mentor
  • letter of support the chair of the applicant’s academic unit
  • letter of support from a faculty member familiar with the applicant’s research potential

Selection Process

Applicants who display the highest potential for success as research scientists will be selected as program scholars. The choice will be made on the basis of academic qualifications, training background, performance record during professional training (coursework during medical, dental, nursing, pharmacy school), and research accomplishments (papers, abstracts, or other presentations of original work). Importantly, applicants will be judged on the basis of their potential to develop into a successful translational/clinical researcher with leadership skills, as evidenced by previous leadership roles and letters of recommendation. 

Funding / Support Provided

The TL1 will provide salary support at NIH NRSA levels ($24,324 in FY2018), partial tuition and $1,000 travel funds to present research at the Association for Clinical and Translational Science (ACTS) meeting.